NAPLEX Practice Exam 2026 – Comprehensive Test Preparation

Question: 1 / 1820

What is the recommended management for Myelosuppression-induced Neutropenia?

Antibiotics

Colony-stimulating factors

Myelosuppression-induced neutropenia refers to a condition where there is a decrease in white blood cells, particularly neutrophils, due to suppression of the bone marrow. The recommended management for this condition is the use of colony-stimulating factors. Colony-stimulating factors such as granulocyte colony-stimulating factor (G-CSF) or granulocyte-macrophage colony-stimulating factor (GM-CSF) can help stimulate the production of white blood cells, specifically neutrophils, to combat the neutropenia. This treatment option aims to increase the neutrophil count and reduce the risk of infection in affected individuals.

Antibiotics (Choice A) may be used in the presence of an infection but are not the primary recommended management for neutropenia itself. RBC transfusions (Choice C) and platelet transfusions (Choice D) are not indicated for managing myelosuppression-induced neutropenia.

Get further explanation with Examzify DeepDiveBeta

RBC transfusions

Platelet transfusions

Next Question

Report this question

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy